Rahul Aggarwal

Also affiliated with UCSF Helen Diller Family Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 47 papers. Top paper: “Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer”.

Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002254

N/A

1.6DataRank · unranked

72 citations

Li Zhang, Sumit K. Subudhi, Brandon Chen, Jaqueline Marquez, Eric V Liu +12 more

Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial

Nature Communications(2024)10.1038/s41467-023-44514-2

N/A

1.3DataRank · unranked

49 citations

Mary‐Ellen Taplin, Rahul Aggarwal, Laura A. Sena, Hao Wang, Hanfei Qi +15 more

Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas

British Journal of Cancer(2023)10.1038/s41416-023-02298-8

N/A

0.681DataRank · unranked

11 citations

Jennifer A. Chan, Stephanie J. Wang, Rahul Aggarwal, Susan Calabrese, April DeMore +13 more

Resistance to Androgen Deprivation Leads to Altered Metabolism in Human and Murine Prostate Cancer Cell and Tumor Models

Metabolites(2021)10.3390/metabo11030139

N/A

0.470DataRank · unranked

22 citations

Robert Bok, Justin Delos Santos, Deepti Upadhyay, Romelyn Delos Santos, Shubhangi Agarwal +7 more

Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer

European Urology Oncology(2023)10.1016/j.euo.2023.11.014

N/A

0.442DataRank · unranked

18 citations

Fadi Taza, Navonil De Sarkar, Alok K. Tewari, Syed Arsalan Ahmed Naqvi, Irbaz Bin Riaz +32 more

Androgen-deprivation therapy and SARS-CoV-2 in men with prostate cancer: findings from the University of California Health System registry

Annals of Oncology(2021)10.1016/j.annonc.2021.01.067

N/A

0.406DataRank · unranked

14 citations

H.T. Borno, R.R. Aggarwal, E.J. Small, Daniel H. Kwon, Rohit Vashisht +6 more

A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)

Prostate Cancer and Prostatic Diseases(2024)10.1038/s41391-024-00798-z

N/A

0.345DataRank · unranked

9 citations

Russell K. Pachynski, Samuel R. Denmeade, Rahul Aggarwal, Jiehui Deng, Victor Adorno Febles +27 more

Updated results of phase II trial using escalating doses of neoadjuvant atezolizumab for cisplatin-ineligible patients with nonmetastatic urothelial cancer (NCT02451423).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e16510

N/A

0.269DataRank · unranked

5 citations

Li Zhang, David Y. Oh, Sima P. Porten, Maxwell V. Meng, Raj S. Pruthi +15 more

The impact of prior radiation therapy on outcome in a phase 2 trial combining sipuleucel-T (SipT) and ipilimumab (Ipi) in patients (pts) with metastatic castration resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5045

N/A

0.241DataRank · unranked

4 citations

Meenal Sinha, Sumit K. Subudhi, Brandon Chen, Jaqueline Marquez, Eric Liu +12 more

Specialized computational methods for denoising, B1 correction, and kinetic modeling in hyperpolarized 13C MR EPSI studies of liver tumors

Magnetic Resonance in Medicine(2021)10.1002/mrm.28901

N/A

0DataRank · unranked

13 citations

Hsin‐Yu Chen, Jeremy W. Gordon, Zihan Zhu, Peder E. Z. Larson, Nicholas Dwork +11 more

Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing

JCO Precision Oncology(2021)10.1200/po.20.00428

N/A

0DataRank · unranked

11 citations

Clinton L. Cario, Lancelote Leong, Karen López, César Márquez, Patricia Li +14 more

Immunogenic priming with 177Lu-PSMA-617 plus pembrolizumab in metastatic castration resistant prostate cancer (mCRPC): A phase 1b study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5053

N/A

0DataRank · unranked

32 citations

Srey Luch Sam, Vadim S. Koshkin, Eric J. Small, Felix Y. Feng, Ivan de Kouchkovsky +12 more

Phase II trial of escalating doses of neoadjuvant atezolizumab for patients with non-metastatic urothelial carcinoma ineligible for cisplatin-based neoadjuvant chemotherapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.442

N/A

0DataRank · unranked

8 citations

Divya Natesan, Li Zhang, David Y. Oh, Sima P. Porten, Maxwell V. Meng +6 more

5-hydroxymethylcytosine as a liquid biopsy biomarker in mCRPC.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.148

N/A

0DataRank · unranked

3 citations

Shuang G. Zhao, Eric J. Small, Yuhong Ning, Corinne Maurice‐Dror, Adam Foye +15 more

Differential responses to taxanes and PARP inhibitors (PARPi) in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer (mCRPC) patients (pts).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5040

N/A

0DataRank · unranked

0 citations

Emily Nizialek, Jacob E. Berchuck, Panagiotis J. Vlachostergios, Ryan Ashkar, Alexandra Sokolova +14 more

CUB domain containing protein 1 (CDPC1) is a target for radioligand therapy in castration resistant prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.17.448569

N/A

0DataRank · unranked

0 citations

Kai Trepka, Yung-Hua Wang, Shalini Chopra, Nima Hooshdaran, Hyun‐Jung Kim +14 more

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

Cancer Research(2022)10.1158/0008-5472.can-22-1123

N/A

0DataRank · unranked

67 citations

Shuang G. Zhao, Samuel Levy, Meng Zhang, Yuhong Ning, Raunak Shrestha +58 more

Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer

Cancer Research(2022)10.1158/0008-5472.can-22-1433

N/A

0DataRank · unranked

61 citations

Emily A. Egusa, Sinan Wang, Michelle L. Badura, Fei Lee, Anil P. Bidkar +22 more

CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3858

N/A

0DataRank · unranked

30 citations

Shalini Chopra, Kai Trepka, Yung-Hua Wang, Sasank Sakhamuri, Nima Hooshdaran +18 more

Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2567

N/A

0DataRank · unranked

26 citations

Nicholas R. Rydzewski, Meng Zhang, Arian Lundberg, Matthew L. Bootsma, Kyle T. Helzer +7 more

Quality of life for men with metastatic castrate-resistant prostate cancer participating in an aerobic and resistance exercise pilot intervention

Urologic Oncology Seminars and Original Investigations(2022)10.1016/j.urolonc.2022.11.016

N/A

0DataRank · unranked

19 citations

Yea‐Hung Chen, Erin L. Van Blarigan, June M. Chan, Charles J. Ryan, Li Zhang +16 more

Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer

Clinical Genitourinary Cancer(2023)10.1016/j.clgc.2023.02.010

N/A

0DataRank · unranked

58 citations

Michael T. Schweizer, Kim N., Rahul Aggarwal, Neeraj Agarwal, James L. Gulley +9 more

A phase 2 study of the WEE1 inhibitor AZD1775 in SETD2-deficient advanced solid tumor malignancies.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.3104

N/A

0DataRank · unranked

3 citations

W. Kimryn Rathmell, Geoffrey I. Shapiro, Jordi Rodon Ahnert, Devalingam Mahalingam, Nikolaos A. Trikalinos +9 more

Data from Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET

(2023)10.1158/1078-0432.c.6529904

N/A

0DataRank · unranked

0 citations

Jun Li, Jun Hua, Yang Su, Denis Beckford-Vera, Walter Zhao +20 more

A multi-center natural history study of precision-based genomics in prostate cancer (PC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps5121

N/A

0DataRank · unranked

0 citations

Joaquı́n Mateo, Wassim Abida, Rana R. McKay, Bruce Montgomery, Rahul Aggarwal +5 more

Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer

Nature Genetics(2024)10.1038/s41588-024-01826-3

N/A

0DataRank · unranked

38 citations

Matthew L. Bootsma, Stanley Zhou, Raunak Shrestha, Thaidy Moreno-Rodriguez, Arian Lundberg +41 more

An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression

Cancer Research(2024)10.1158/0008-5472.can-24-0890

N/A

0DataRank · unranked

27 citations

Lisa N. Chesner, Meng Zhang, Stanley Zhou, Adam Foye, Arian Lundberg +13 more

Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-2061

N/A

0DataRank · unranked

27 citations

Michael J. Morris, Chien‐Kuang Cornelia Ding, Erolcan Sayar, Rohit Mehra, Brian D. Robinson +10 more

Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression

Nature Cell Biology(2024)10.1038/s41556-024-01438-3

N/A

0DataRank · unranked

18 citations

Martin Sjöström, Xiekui Cui, Adam Foye, Kyle Kai‐How Farh, Raunak Shrestha +12 more

Prostate‐Specific Membrane Antigen Targeted StarPEG Nanocarrier for Imaging and Therapy of Prostate Cancer

Advanced Healthcare Materials(2024)10.1002/adhm.202304618

N/A

0DataRank · unranked

11 citations

Gary W. Ashley, Kondapa Naidu Bobba, Anju Wadhwa, Anil P. Bidkar, Chandrashekhar Dasari +14 more

Dual hyperpolarized [1-13C]pyruvate and [13C]urea magnetic resonance imaging of prostate cancer

Journal of Magnetic Resonance Open(2024)10.1016/j.jmro.2024.100165

N/A

0DataRank · unranked

8 citations

Hao Nguyen, Hsin‐Yu Chen, Xiaoxi Liu, Hecong Qin, Bradley A. Stohr +14 more

A prostate cancer gastrointestinal transcriptional phenotype may be associated with diminished response to AR-targeted therapy

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.06.02.595931

N/A

0DataRank · unranked

0 citations

Meng Zhang, Marina N. Sharifi, Thaidy Moreno-Rodriguez, Eric Feng, Nicholas R. Rydzewski +9 more

Correlating survival outcomes in patients with advanced prostate cancer with novel hyperpolarized 13C MRI metabolic imaging biomarkers.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.e15059

N/A

0DataRank · unranked

0 citations

Ivan de Kouchkovsky, Robert Bok, Michael A. Ohliger, Zhen J. Wang, Daniel Gebrezgiabhier +8 more

Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac Therapy

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2850

N/A

0DataRank · unranked

10 citations

Robin Peter, Anju Wadhwa, Kondapa Naidu Bobba, Scott Bidlingmaier, Niranjan Meher +19 more

PROX1 is an early driver of lineage plasticity in prostate cancer

Journal of Clinical Investigation(2025)10.1172/jci187490

N/A

0DataRank · unranked

9 citations

Mingchen Shi, Anbarasu Kumaraswamy, Dong Lin, Dhruv Khokhani, Yong Wang +41 more

Secondary analysis of the EMPACT-MI trial reveals cardiovascular–kidney efficacy and safety of empagliflozin after acute myocardial infarction

Nature Cardiovascular Research(2025)10.1038/s44161-025-00657-7

N/A

0DataRank · unranked

3 citations

Deepak L. Bhatt, Adrian F. Hernandez, Stefan D. Anker, Josephine Harrington, W. Schuyler Jones +8 more

Multivariate Framework of Metabolism in Advanced Prostate Cancer Using Whole Abdominal and Pelvic Hyperpolarized 13C MRI—A Correlative Study with Clinical Outcomes

Cancers(2025)10.3390/cancers17132211

N/A

0DataRank · unranked

3 citations

Ivan de Kouchkovsky, Robert Bok, Michael A. Ohliger, Zhen J. Wang, Daniel Gebrezgiabhier +8 more

Adverse prognosis gene expression patterns in metastatic castration‐resistant prostate cancer

Molecular Oncology(2025)10.1002/1878-0261.70001

N/A

0DataRank · unranked

4 citations

Eric Feng, Nicholas R. Rydzewski, Amy K. Taylor, Jamie M. Sperger, Yue Shi +22 more

Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer

npj Precision Oncology(2025)10.1038/s41698-025-01002-8

N/A

0DataRank · unranked

1 citations

Ya‐Mei Hu, Joel A. Yates, Chao Zhang, Eva S. Rodansky, Dhruv Khokhani +26 more

Autoantibody Landscape in Patients with Advanced Prostate Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1966

N/A

0DataRank · unranked

20 citations

Winston Haynes, Rebecca Waitz, Kathy Kamath, Agustin Vega-Crespo, Raunak Shrestha +26 more

Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2303

N/A

0DataRank · unranked

13 citations

Duanchen Sun, Eric Lu, Joshua A. Urrutia, Robert E. Reiter, Matthew B. Rettig +17 more

Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3310

N/A

0DataRank · unranked

41 citations

Jun Li, Jun Hua, Su Yang, Denis Beckford-Vera, Walter Zhao +20 more

Differential expression of PSMA and 18F-fluciclovine transporter genes in metastatic castrate-resistant and treatment-emergent small cell/neuroendocrine prostate cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.24

N/A

0DataRank · unranked

5 citations

Mohammed Alshalalfa, Martin Sjöström, Shuang G. Zhao, Annika Herlemann, Jonathan Chou +14 more

Autoantibody landscape of advanced prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.02.074575

N/A

0DataRank · unranked

0 citations

Winston Haynes, Rebecca Waitz, Kathy Kamath, Agustin Vega-Crespo, Raunak Shrestha +25 more

Cell-free DNA as a biomarker for prostate cancer: elevated concentration and decreased fragment size

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.07.26.215020

N/A

0DataRank · unranked

0 citations

Clinton L. Cario, Lancelote Leong, Karen López, César Márquez, Carissa Chu +14 more

Cell-free DNA concentration and fragment size as a biomarker for prostate cancer

Scientific Reports(2021)10.1038/s41598-021-84507-z

N/A

0DataRank · unranked

79 citations

Clinton L. Cario, Lancelote Leong, Karen López, César Márquez, Carissa Chu +14 more

Hyperpolarized 1-[13C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Immune Checkpoint Inhibitor Therapy in Prostate Cancer

European Urology(2021)10.1016/j.eururo.2021.10.015

N/A

0DataRank · unranked

28 citations

Hsin‐Yu Chen, Michael A. Ohliger, Zhen J. Wang, Robert Bok, Jeremy W. Gordon +8 more